New Delhi: Roche has announced its partnership with the digital health company Wellthy Therapeutics to offer users of the Accu-Chek Active system an innovative artificial intelligence-based digital diabetes coaching solution.
Being a leader in diabetes management solutions worldwide, Roche will expand its integrated diabetes management offering through the collaboration with Wellthy Therapeutics. The joint offering of the two companies will encompass the trusted Accu-Chek Active blood glucose meter and the Wellthy Care app to new users. The bundle is being launched in the South and West Zones of India.
Roche cooperates with Wellthy Therapeutics to offer an innovative artificial intelligence-based coaching app to people with type 2 diabetes in South and West India.